Showing results (191-200 of 259) with videos related to
Sort By:
Pageof 26
Blood|September 6, 2018
Notch signaling mediated by Delta-like ligands 1 and 4 controls the pathogenesis of chronic GVHD in miceVedran Radojcic, Katelyn Paz, Jooho Chung, et al.Cancer Research|June 25, 2009
Active Notch1 confers a transformed phenotype to primary human melanocytesChelsea C Pinnix, John T Lee, Zhao-Jun Liu, et al.Proceedings of the National Academy of Sciences of the United States of America|November 6, 2014
Long-range enhancer activity determines Myc sensitivity to Notch inhibitors in T cell leukemiaYumi Yashiro-Ohtani, Hongfang Wang, Chongzhi Zang, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 16, 2020
GCNT1-Mediated O-Glycosylation of the Sialomucin CD43 Is a Sensitive Indicator of Notch Signaling in Activated T CellsEric Perkey, Dave Maurice De Sousa, Léolène Carrington, et al.Medrxiv : the Preprint Server for Health Sciences|August 21, 2020
Rates of COVID-19-related Outcomes in Cancer compared to non-Cancer PatientsLova Sun, Sanjna Surya, Anh N Le, et al.The Journal of Clinical Investigation|March 5, 2013
Blockade of individual Notch ligands and receptors controls graft-versus-host diseaseIvy T Tran, Ashley R Sandy, Alexis J Carulli, et al.JNCI Cancer Spectrum|February 8, 2021
Rates of COVID-19-Related Outcomes in Cancer Compared With Noncancer PatientsLova Sun, Sanjna Surya, Anh N Le, et al.Nature Medicine|May 23, 2018
An immune-beige adipocyte communication via nicotinic acetylcholine receptor signalingHeejin Jun, Hui Yu, Jianke Gong, et al.Blood|May 26, 2023
DLBCL-associated NOTCH2 mutations escape ubiquitin-dependent degradation and promote chemoresistanceNan Zhou, Jaewoo Choi, Grant Grothusen, et al.Immunity|November 3, 2015
The PIAS-like Coactivator Zmiz1 Is a Direct and Selective Cofactor of Notch1 in T Cell Development and LeukemiaNancy Pinnell, Ran Yan, Hyo Je Cho, et al.Pageof 26